This is a non-core endpoint: only basic statistics are computed.
Benign neoplasm: Lacrimal gland and duct
DOID EFO MESH SNOMED Endpoint Browser
CD2_BENIGN_LACRIMAL
choriocarcinoma: An aggressive malignant tumor arising from trophoblastic cells. The vast majority of cases arise in the uterus and represent gestational choriocarcinomas that derive from placental trophoblastic cells. Approximately half of the cases develop from a complete hydatidiform mole. A minority of cases arise in the testis or the ovaries. There is often marked elevation of human chorionic gonadotropin (hCG) in the blood. Choriocarcinomas disseminate rapidly through the hematogenous route; the lungs are most frequently affected.
Endpoint definition
↥
FinnGen phenotype data
429209 individuals
Apply sex-specific rule None
429209
Check conditions None
429209
Check pre-conditions, main-only, mode, registry filters
Hospital Discharge: ICD-10
D31.5&
Hospital discharge: ICD-9
2247
Cause of death: ICD-10
D31.5&
Cause of death: ICD-9
2247
2 out of 7 registries used, show all original rules.
31
Check minimum number of events None
31
Include endpoints None
31
Remove individuals based on genotype QC
30
CD2_BENIGN_LACRIMAL
Control definitions
Controls for this endpoint are individuals that are not cases.
Extra metadata
Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D31
Name in latin
Neoplasma benignum glandulae lacrimalis
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Lacrimal gland and duct
based on the number of shared cases.
Broader endpoints:
- Benign neoplasm: Lacrimal gland and duct (controls excluding all cancers)
- Benign neoplasm of eye and adnexa
- Benign neoplasm of eye and adnexa (controls excluding all cancers)
- Benign neoplasms (controls excluding all cancers)
- Benign neoplasms
Narrower endpoints:
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 30 | 24 | 6 |
| Unadjusted prevalence (%) | 0.01 | 0.01 | 0.00 |
| Mean age at first event (years) | 58.76 | 59.22 | 56.90 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: CD2_BENIGN_LACRIMAL – Benign neoplasm: Lacrimal gland and duct
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Benign neoplasm: Lacrimal gland and duct
↥Endpoint not on priority list, no data to show.